Viatris VTRS
NASDAQ VTRS
$16.48 -0.14 (-0.81%)
As of: Sep 9, 2026 · 2:42 PM EDT

Viatris (VTRS) Sales of Property, Plant and Equipment (2020 - 2026)

Analysis

Viatris (VTRS) Sales of Property, Plant and Equipment (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Teva Pharmaceutical Industries 42.60 Bn 38.94 Bn 2.15 Bn -
2 Viatris 19.15 Bn 18.27 Bn 1.46 Bn 8.20 Mn
3 Dr Reddys Laboratories 9.86 Bn 9.69 Bn 396.53 Mn 3.76 Mn
4 Amneal Pharmaceuticals 5.49 Bn 5.36 Bn 334.51 Mn -
5 Bausch Health Companies 2.35 Bn 516.55 Mn 2.10 Bn -
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -
8 Amphastar Pharmaceuticals 996.17 Mn 706.05 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 404.39 Mn 363.15 Mn 17.15 Mn -
10 RedHill Biopharma 176.59 Mn 176.59 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.20 Mn
Mar 31, 2026 1.60 Mn
Dec 31, 2025 21.20 Mn
Sep 30, 2025 800,000.00
Jun 30, 2025 1.60 Mn
Mar 31, 2025 11.30 Mn
Dec 31, 2024 500,000.00
Sep 30, 2024 800,000.00
Jun 30, 2024 700,000.00
Mar 31, 2024 700,000.00
Dec 31, 2023 600,000.00
Sep 30, 2023 300,000.00
Jun 30, 2023 12.40 Mn
Mar 31, 2023 700,000.00
Dec 31, 2022 400,000.00
Sep 30, 2022 600,000.00
Jun 30, 2022 7.70 Mn
Mar 31, 2022 5.10 Mn
Dec 31, 2021 2.20 Mn
Sep 30, 2021 600,000.00